Suspension of conventional sales activities to help prevent the spread of infectious diseases
First written in FY2021-Q3. 5 of 6 entries say "Mitigated", first in FY2022-Q2. Latest entry: FY2024-Q1.
No other company in this theme has enough history to compare yet.
- FY2024-Q1MitigatedAnnual report
「As restrictions on visits to medical institutions were eased and sales activities in Japan and overseas recovered, travel and transportation expenses and advertising expenses increased」
Regarding visits to medical institutions and sales activities that had been restricted to prevent the spread of infectious diseases, it states that restrictions on visits were eased and sales activities in Japan and overseas recovered. - FY2023MitigatedAnnual report
「Following the reclassification of the novel coronavirus infection as a Category V disease, healthcare and nursing care institutions also eased their emergency response frameworks, and conditions have subsided.」
Regarding visits to medical institutions and sales activities that had been restricted to prevent the spread of infectious diseases, it describes the easing and subsiding of emergency response measures. - FY2023-Q1MitigatedAnnual report
「As restrictions on visits to medical institutions were eased and sales activities in Japan and overseas recovered, travel and transportation expenses and exhibition expenses increased, resulting in a 2.7% year-on-year increase.」
Regarding restrictions on sales activities associated with preventing the spread of infectious diseases, restrictions on visits to medical institutions were eased and sales activities in Japan and overseas are recovering. - FY2022MitigatedAnnual report
「As restrictions on visits to medical institutions were eased and sales activities in Japan and overseas recovered, travel and transportation expenses increased」
Regarding restrictions on sales activities associated with preventing the spread of infectious diseases, restrictions on visits to medical institutions were eased and sales activities in Japan and overseas are recovering. - FY2022-Q2MitigatedAnnual report
「As restrictions on visits to medical institutions were eased and sales activities in Japan and overseas recovered」
Regarding restrictions on sales activities associated with preventing the spread of infectious diseases, it states that restrictions on visits to medical institutions were eased and sales activities in Japan and overseas recovered. - FY2021-Q3First statedAnnual report
「To prevent the spread of COVID-19, we have continued to suspend conventional sales activities and take other measures.」
It describes the continued suspension of conventional sales activities as an independent measure to prevent the spread of infectious diseases and as a factor behind the decline in selling, general and administrative expenses.